Unaudited Condensed Consolidated Statements of Changes in Stockholders' Equity (Deficit) - USD ($) $ in Thousands	Total	Revision of Prior Period, Adjustment	Impact of ASC 326 adoption	Redeemable Noncontrolling Interests	Redeemable Noncontrolling Interests Revision of Prior Period, Adjustment	Common Stock	Additional Paid-In Capital	Additional Paid-In Capital Revision of Prior Period, Adjustment	Noncontrolling Interests	Noncontrolling Interests Revision of Prior Period, Adjustment	Accumulated Deficit	Accumulated Deficit Impact of ASC 326 adoption
Balance (in shares) at Dec. 31, 2021						140,540,671
Balance at Dec. 31, 2021	$ 361,810					$ 14	$ 461,207		$ 0		$ (99,411)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options (in shares)						1,312,320
Exercise of stock options	$ 258						258
Issuance of restricted stock (in shares)						2,205
Issuance of shares as contingent consideration relating to Quantum business acquisition (in shares)	100,000
Issuance of shares as contingent consideration relating to Quantum business acquisition	$ 186						186
Stock-based compensation expense	381						381
Net loss	(16,077)										(16,077)
Balance (in shares) at Mar. 31, 2022						141,955,196
Balance at Mar. 31, 2022	346,558					$ 14	462,032		0		(115,488)
Beginning balance at Dec. 31, 2022				$ 85
Increase (Decrease) in Temporary Equity [Roll Forward]
Capital distributions to noncontrolling interests				(108)
Net income (loss)				(39)
Ending balance at Mar. 31, 2023				$ 178
Balance (in shares) at Dec. 31, 2022						144,375,226
Balance at Dec. 31, 2022	288,891		$ 1,285			$ 14	473,277		8,942		(193,342)	$ 1,285
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options (in shares)						1,081,679
Exercise of stock options	283						283
Issuance of restricted stock (in shares)						2,731,919
Issuance of common stock (in shares)						206,546
Issuance of common stock	150						150
Capital distributions to noncontrolling interests	(88)								(88)
Stock-based compensation expense	796						796
Net income / (loss)	(18,805)								590		(19,395)
Net loss	(18,844)
Balance (in shares) at Mar. 31, 2023						148,395,370
Balance at Mar. 31, 2023	$ 265,209					$ 14	$ 472,693		$ 3,954		$ (211,452)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Temporary Equity, Fair Value Adjustment For Acquisition					240,000
Adjustments To Additional Paid In Capital, Fair Value Adjustment For Acquisition		$ (7,303)						$ (1,813)		$ (5,490)